GlassScriptPhysician profile
Maulik Shah
NPI 1154592061
$10,122.41
in general payments reported to CMS, 2019-2025
51 companies · $1,480 in 2025
The $1,480 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,475 · 2020: $523 · 2021: $1,099 · 2022: $1,603 · 2023: $2,183 · 2024: $1,759 · 2025: $1,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,369 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,369.17 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,348.89 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,313.79 | 2019-2025 | |
| Abbott Laboratories | $843.12 | 2019-2025 | Mitraclip, Xience Skypoint, Optis |
| Merck Sharp & Dohme LLC | $564.05 | 2021-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $475.89 | 2019-2025 | Lifevest |
| Philips North America LLC | $470.78 | 2021-2025 | (P84) Igt Devices Systems, Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und |
| Inari Medical, INC. | $448.34 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $405.42 | 2019-2025 | Farxiga, Brilinta |
| Janssen Pharmaceuticals, INC | $383.42 | 2019-2024 | Xarelto |
| Pfizer INC. | $370.32 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $268.89 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $255.76 | 2021-2025 | Jardiance |
| Atricure, INC. | $255.19 | 2023-2024 | |
| Medtronic, INC. | $253.94 | 2021-2023 | Corevalve Evolut R |
| Heartflow, INC. | $252.24 | 2023-2025 | Ffrct |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $228.36 | 2019-2025 | Watchman Flx, General - Vascular Intervention |
| Alnylam Pharmaceuticals INC. | $215.22 | 2021-2025 | Amvuttra |
| Novo Nordisk INC | $171.26 | 2023-2025 | Wegovy, Ozempic |
| Bardy Diagnostics, INC. | $145.00 | 2019 | |
| Esperion Therapeutics, INC. | $126.59 | 2021-2023 | Nexletol |
| Edwards Lifesciences Corporation | $103.63 | 2019-2025 | Sapien 3 Ultra Resilia |
| Aerin Medical INC. | $93.49 | 2023-2024 | |
| Glaxosmithkline, LLC. | $89.66 | 2023-2025 | Nucala, Arexvy, Shingrix |
| Kiniksa Pharmaceuticals, LTD. | $86.85 | 2021-2023 | Arcalyst |
| Biosense Webster, INC. | $75.85 | 2024-2025 | Carto 3 |
| Regeneron Healthcare Solutions, INC. | $69.95 | 2019 | |
| Amarin Pharma, INC. | $64.97 | 2019 | |
| Kestra Medical Technology Services, INC. | $60.10 | 2023-2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $59.49 | 2023-2025 | Opsumit, Uptravi |
| Biotronik INC. | $52.52 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.67 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $47.01 | 2023-2024 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $41.29 | 2024 | Arcalyst |
| Chiesi USA, INC. | $41.12 | 2023-2024 | Kengreal, Cleviprex, Juxtapid |
| Lundbeck LLC | $39.24 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $34.38 | 2023-2024 | Inpefa |
| Impulse Dynamics (USA) INC. | $32.58 | 2022 | |
| Cardiva Medical, INC. | $27.97 | 2021 | |
| Medtronic Vascular, INC. | $27.84 | 2020 | |
| Ge Healthcare | $27.53 | 2019 | |
| Endotronix, INC. | $24.17 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Cardiovascular Systems INC. | $23.55 | 2019 | |
| Lilly USA, LLC | $22.19 | 2025 | Mounjaro, Zepbound |
| Irhythm Technologies, INC. | $19.88 | 2019 | |
| Stryker Corporation | $18.76 | 2023 | Scopis Ent |
| Baxter Healthcare | $18.61 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Medicure Pharma INC. | $18.35 | 2019 | |
| Inspire Medical Systems, INC. | $17.02 | 2025 | Inspire |
| Allergan, INC. | $14.16 | 2019 | |
| Penumbra, INC. | $12.67 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maulik Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.